Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Affiliations

• ¹ Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
• ² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
• ³ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
• ⁴ Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
• ⁵ Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Luebeck, Germany.
• ⁶ Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.